Unity Biotechnology, Inc.   (NASDAQ:UBX)

0.76    $-0.06   -7.12%
Market open   Tuesday, May 24 2022 10:48 AM

Unity Biotechnology, Inc. Chart

UBX Stock Price Today

Unity Biotechnology, Inc. (UBX) stock plummeted over -7.12% intraday to trade at $0.76 a share on NASDAQ. The stock opened with a gain of 0.00% at $0.82 and touched an intraday high of $0.85, rising 3.66% against the last close of $0.82. The stock went to a low of $0.79 during the session.

Stock Snapshot

0.82
Prev. Close
0.82
Open
58.99M
Market Cap
67.53M
Number of Shares
0.79
day Low
0.85
Day High
0.76
-
P/E ratio
1.06%
Free Float in %
-1.08
EPS (TTM)
0.75
Book Value per Share
1.10
Cash Flow per Share
130782
Volume

Unity Biotechnology, Inc. Historical Data

DateOpenCloseDaily HighDaily LowVolume
2022-05-20$0.84$0.79$0.85$0.79254,100
2022-05-19$0.80$0.82$0.86$0.79200,900
2022-05-18$0.81$0.82$0.86$0.80161,500
2022-05-17$0.79$0.85$0.85$0.79235,300
2022-05-16$0.79$0.79$0.83$0.78233,800
2022-05-13$0.78$0.81$0.83$0.75287,800
2022-05-12$0.72$0.74$0.78$0.71370,200
2022-05-11$0.80$0.73$0.81$0.73323,400
2022-05-10$0.75$0.77$0.79$0.74370,200
2022-05-09$0.84$0.76$0.85$0.75593,500
2022-05-06$0.91$0.85$0.91$0.82279,900

Contact Details

285 East Grand Avenue
South San Francisco, CA 94080
United States
https://unitybiotechnology.com
650 416 1192

Company Information

Employees76
Beta0.40
Sales or Revenue4.80M
5Y Sales Change-%
Fiscal Year Ends2021-12-30
SectorHealthcare
IndustryBiotechnology

About Company

Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular degeneration, and diabetic retinopathy. It also develops UBX1967 for the treatment of ophthalmologic diseases; UBX2050, a human anti-Tie2 agonist monoclonal antibody for the treatment of age-related eye diseases; and UBX2089, a a-Klotho hormone drug candidate for multiple neurology indications. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California.

Frequently Asked Questions

What is the current Unity Biotechnology, Inc. (UBX) stock price?

Unity Biotechnology, Inc. (NASDAQ: UBX) stock price is $0.76 as of the last check on Tuesday, May 24 2022. During the trading session, UBX stock reached the peak price of $0.85 while $0.79 was the lowest point it dropped to.

UBX's industry and sector of operation?

The NASDAQ listed UBX is part of Biotechnology industry that operates in the broader Healthcare sector. Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging.

Who are the executives of UBX?

Dr. Nathaniel E. David
Co-Founder & Exec. Director

Dr. Anirvan Ghosh
CEO & Director

Mr. Daohong Zhou M.D.
Founder

Ms. Lynne Marie Sullivan
Chief Financial Officer


What is the UBX stock price today?

UBX stock is trading at $0.76 today, which is $-0.06 or -7.12% lower than its previous close of $0.82. UBX's current trading price is -85.08% lower than its 52-week high of $5.09 where as its distance from 52-week low of $0.69 is 9.17%.

How many employees does UBX have?

Number of UBX employees currently stands at 76. UBX operates from 285 East Grand Avenue
South San Francisco, CA 94080
United States.

Link for UBX official website?


How do I contact UBX?

UBX could be contacted at 285 East Grand Avenue
South San Francisco, CA 94080
United States, or at phone # 650 416 1192 and can also be accessed through its website: https://unitybiotechnology.com

How many shares of UBX are traded daily?

UBX stock volume so far today is 130782 shares while in the previous session number of UBX shares traded was 254100. The average number of UBX shares traded daily for last 3 months was 534870.

How much did UBX change today?

The percentage change in UBX stock occurred in the recent session was -7.12% while the dollar amount for the price change in UBX stock was $-0.06.

What price range UBX stock been trading in?

In the recent session, the day high for UBX stock was $0.85 while the low for UBX stock touched on the day was $0.79.

What is the market cap of UBX currently?

The market value of UBX currently stands at $58.99M with its latest stock price at $0.76 and 67.53M of its shares outstanding.